Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same
US-12338237-B2 · Jun 24, 2025 · US
This page is not indexed by search engines while we improve data quality.
Patent family 75911384
This patent family groups 3 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 75911384 |
| Family type | — |
| Earliest priority | Nov 15, 2019 |
| First filing country | US |
| Member publications | 3 |
| Countries | US |
| Representative publication | US12338237B2 — Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same |
Representative publication
Best representative member for this family based on priority and filing country.
US12338237B2 — Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same (published Jun 24, 2025)
Member publications
Related publications in this family.
Novel compounds having inhibitory activity against glucosylceramide synthase or pharmaceutically acceptable salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same
US-2023002380-A1 · Jan 5, 2023 · US
Novel derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same
US-2022402909-A1 · Dec 22, 2022 · US